J.P.
In a research report published Tuesday, J.P.
On May 12, the FDA advisory committee recommended that the FDA approve Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)’s Orkambi therapy to treat cystic fibrosis. Shares of …
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) shares are up 8% in after-market trading after the FDA’s advisory committee panel recommended for approval the company’s ORKAMBI cystic fibrosis treatment. By …
Shares of MannKind Corporation (NASDAQ:MNKD) were hammered today after J.P.
